Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 1
1(33.3%)
3Total
N/A(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07486271Not ApplicableRecruiting

Artificial Intelligence in Aortic Regurgitation

Role: collaborator

NCT07316231Recruiting

Evaluating the Accuracy and Practical Utility of AI-Enhanced 12-Lead ECG

Role: lead

NCT06937125Recruiting

Evaluation of Valvular Heart Disease Using Cardiac CT

Role: lead

NCT06651008Completed

The New Transition Factors to Surgery of Duodenal Perforation

Role: lead

NCT04744532Phase 1Unknown

iPSC-based Drug Repurposing for ALS Medicine (iDReAM) Study

Role: collaborator

NCT04728945Not ApplicableUnknown

Prevention of Perioperative Pulmonary Complications by Lung Recruitment During Laparoscopic Surgery

Role: collaborator

NCT01859897Completed

A Prospective Multicenter Study to Evaluate Usefulness of Cardio-Ankle Vascular Index in Japan

Role: collaborator

All 7 trials loaded